Noblesville, IN, United States of America

Jeremy Schulenburg York

This inventor holds 17 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Compounds. Top assignee: Eli Lilly and Company. Active years: 2004-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeremy Schulenburg York. Retrieved from https://idiyas.com/inventor/jeremy-schulenburg-york

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 6)

% Patents Active = 41.2

CIPO Patents = 4

EPO Patents = 10 (Patent Applications = 7)

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 23(Granted Patents)

Location History:

Indianapolis, IN (US) (2004 - 2008)
Noblesville, IN (US) (2009 - 2024)

Company Filing History:

17 out of 4,517

Eli Lilly and Company

patents

Years Active: 2004-2024

Loading Chart...

Areas of Expertise:

RNA Interference Agents

Dimethylbenzoic Acid

Carboxylic Acid Compounds

EP4 Receptor Modulators

Piperidine Compounds

Isoquinoline Compounds

Prostaglandin Inhibitors

Hydroxysteroid Dehydrogenase Inhibitors

Pyrazolopyridine Derivatives

Phenoxyether Derivatives

Pharmaceutical Agents

MRP1 Inhibitors

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11926827 - MAPT RNA interference agents (2024-03-12),

2. 10005721 - Dimethylbenzoic acid compounds (2018-06-26),

3. 9969714 - Carboxylic acid compounds useful for inhibiting microsomal prostaglandin E2 synthase-1 (2018-05-15),

4. 9962375 - [object Object] (2018-05-08),

5. 9776964 - Phenoxyethyl cyclic amine derivatives and their activity as EP4 receptor modulators (2017-10-03),

6. 9402838 - Phenoxyethyl piperidine compounds (2016-08-02),

7. 9371289 - Phenoxyethyl dihydro-1H-isoquinoline compounds (2016-06-21),

8. 8962659 - Phenoxyethyl piperidine compounds (2015-02-24),

9. 8252831 - Imidazole-2-benzamide compounds useful for the treatment of osteoarthritis (2012-08-28),

10. 8088776 - Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 (2012-01-03),

11. 7998999 - Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 (2011-08-16),

12. 7829582 - Piperidinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 (2010-11-09),

13. 7816349 - Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 (2010-10-19),

14. 7608639 - Phenoxyether derivatives as PPAR modulators (2009-10-27),

15. 7365066 - Pyrazolopyridine derivatives as pharmaceutical agents (2008-04-29),

Title: Jeremy Schulenburg York: Innovator in RNA Interference and Pharmaceutical Compounds

Introduction

Jeremy Schulenburg York is a prominent inventor based in Noblesville, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of RNA interference agents and pharmaceutical compounds. With a total of 17 patents to his name, York has established himself as a key figure in innovative research.

Latest Patents

Among his latest patents is the invention of MAPT RNA interference agents. This patent provides compositions comprising a MAPT RNAi agent and methods for using these agents to reduce MAPT expression and treat tauopathy in subjects. Another notable patent involves dimethylbenzoic acid compounds, which are designed as inhibitors of the EP4 receptor, showcasing his versatility in addressing various medical challenges.

Career Highlights

York is currently associated with Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to focus on groundbreaking research that has the potential to impact the treatment of neurological disorders and other health conditions.

Collaborations

Throughout his career, York has collaborated with talented individuals such as Matthew Allen Schiffler and Yanping Xu. These collaborations have fostered an environment of innovation and have contributed to the successful development of his patented technologies.

Conclusion

Jeremy Schulenburg York's contributions to the fields of RNA interference and pharmaceutical compounds highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.